Harvest Investment Services, LLC Novavax Inc Transaction History

Harvest Investment Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$177.8 - $270.58 $259,588 - $395,046	-1,460 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$121.0 - $257.67 $1.26 Million - $2.68 Million	-10,386 Reduced 87.68%	1,460 $309,000
Q1 2021 May 06, 2021	SELL	$112.98 - $319.93 $860,681 - $2.44 Million	-7,618 Reduced 39.14%	11,846 $2.15 Million
Q4 2020 Feb 01, 2021	BUY	$78.74 - $139.5 $270,393 - $479,043	3,434 Added 21.42%	19,464 $2.17 Million
Q3 2020 Oct 29, 2020	SELL	$79.44 - $178.51 $282,012 - $633,710	-3,550 Reduced 18.13%	16,030 $1.74 Million

Q2 2020 Aug 11, 2020	BUY	$13.86 - $83.61 $271,378 - $1.64 Million	19,580 New	19,580 $1.63 Million

243

76.1M

5.06M

7.19M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $931M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Investment Services, LLC with notifications on news.